Quantité totale PI	37
Rang # Quantité totale PI	38 587
Note d'activité PI	2,4/5.0    32
Rang # Activité PI	24 140
Symbole boursier	ACLX (nasdaq)
ISIN	US03940C1009
Capitalisation	4,600M  (USD)
Classe Nice dominante	Produits pharmaceutiques, vétéri...

Brevets Marques 16 2 7 1 7 0 4
Dernier brevet	2025 - D-domain containing polypeptides...
Premier brevet	2016 - De novo binding domain containin...
Dernière marque	2022 - ARCELLX
Première marque	2017 - ARCELLX

Industrie (Classification de Nice)

Derniers inventions, produits et services 2025 Invention D-domain containing polypeptides and uses thereof. D domain (DD) containing polypeptides (DDpp) ... 2024 Invention Multifunctional immune cell therapies. Provided herein are multi-functional chimeric antigen rec... 2023 Invention D-domain containing polypeptides and uses thereof Invention D-domain containing polypeptides and uses thereof. in vitroinvivo.vivo. Invention D-domain containing polypeptides and uses thereof. Provided herein are D domain containing polyp... 2022 Invention D-domain containing polypeptides and uses thereof. Provided herein are D domain containing polype... P/S Biological preparations for the treatment of cancer using genetically engineered cells; pharmaceu... Invention Multifunctional immune cell therapies. Provided herein are multi-functional chimeric antigen rece... Invention Multifunctional immune cell therapies. in vitroin vivoin vivo. In some embodiments, the CAR cell ... 2021 Invention De novo binding domain containing polypeptides and uses thereof. Provided herein are de novo bin... 2020 Invention De novo binding domain containing polypeptides and uses thereof. Provided herein are de novo bind... 2018 Invention D-domain containing polypeptides and uses thereof. D domain (DD) containing polypeptides (DDpp) t... Invention D-domain containing polypeptides and uses thereof. e.ge.g., BCMA, CD123, CS1, HER2, AFP, and AFP ... 2017 P/S Pharmaceutical preparations for targeting tissues based on select tissue markers and ligands for ...